XPEL Inc (NASDAQ: XPEL) has reported earnings for its third fiscal quarter (ending September 30) of $0.49 versus $0.48 for the same period a year ago — an increase of 2%. However, this result fell […]
Travere Therapeutics Inc (NASDAQ: TVTX) stock suffered a major decline of -11.8% on 11/8/23. The shares closed at $6.33. The stock has been extremely weak relative to the market over the last nine months and […]
For its fourth fiscal quarter (ending September 30), Helmerich & Payne Inc. (NYSE: HP) has reported a 86% increase in E.P.S. from $0.42 a year ago to $0.78 in the current quarter. This performance was […]
VistaGen Therapeutics Inc (NASDAQ: VTGN) stock closed at $3.08 on 11/8/23 after a major decline of -11.4%. Relative to the market the stock has been weak over the last nine months and has declined -3.1% […]
Atmos Energy Corp (NYSE: ATO) has reported earnings for its fourth fiscal quarter (ending September 30) of $0.80 versus $0.51 for the same period a year ago — an increase of 57%. This result exceeded […]
For its third fiscal quarter (ending September 30), Computer Task Group Inc (NASDAQ: CTG) has reported a -175% decline in E.P.S. from $0.08 a year ago to $-0.06 in the current quarter. For the latest […]
Envestnet Inc (NYSE: ENV) has reported E.P.S. of $0.13 for its third fiscal quarter (ending September 30) versus $-0.13 for the same period a year ago. Relative to the consensus estimate of $0.54, this was […]
Amicus Therapeutics Inc (NASDAQ: FOLD) has reported E.P.S. of $-0.07 for its third fiscal quarter (ending September 30) versus $-0.12 for the same period a year ago. Relative to the consensus estimate of $-0.08, this […]
Under Armour Inc (NYSE: UAA) has reported E.P.S. of $0.25 for its second fiscal quarter (ending September 30) versus $0.19 for the same period a year ago — an increase of 32%. Recent Price Action […]
Topgolf Callaway Brands Corp (NYSE: MODG) has reported E.P.S. of $0.16 for its third fiscal quarter (ending September 30) versus $0.21 for the same period a year ago — a decline of -24%. However, this […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research